Enzene will be attending BPS 2025 and looks forward to connecting with biopharmaceutical organizations seeking strategic CDMO partnerships.
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.